As we have seen in recent years, there is no “one-size-fits-all” approach to ensure diversity, equity, and inclusion in clinical trials. Join “PharmaVoice 100” thought leaders Aman Khera, Vice President and Global Head of Regulatory Strategy at Worldwide Clinical Trials in conversation with Amanda Ryan, President of G3 Life Sciences, as they dive into considerations when developing an effective clinical trial diversity strategy, including the effectiveness of designated DEI roles in the process, the application of playbooks, tailoring community engagement to establish and build trust, and empowering the entire organization to make a difference